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Intercellular adhesion molecule-1 (ICAM-1) is expressed on a variety of cells including endothelial
cells, alveolar epithelial cells, and alveolar macrophages. Endothelial/epithelial cell ICAM-1
participates in the migration of leukocytes out of the blood in response to pulmonary inflammation,
whereas alveolar macrophage ICAM-1 may represent cell activation. Our previous studies have
shown that there is increased expression of ICAM-1 in lung tissue during acute inflammation
following intratracheal injection with silica particles (2 mg/mouse). This increased expression was
shown to play a role, in part, in the migration of neutrophils from the circulation into the tissue
parenchyma. The aim of the current work is to localize expression of ICAM-1 during acute
inflammation in lungs of mice exposed to either silica or the nuisance dust, titanium dioxide. In
silica-exposed mice, a significant increase in ICAM-1 was detected on day 1 and localized by
immunohistochemistry to aggregates of pulmonary macrophages and to type 11 epithelial cells.
Areas of the lung with increased ICAM-1 expression also showed increased tumor necrosis
factor alpha expression. Immunocytochemical staining of bronchoalveolar lavage (BAL) cells
demonstrated increased ICAM-1 expression associated with alveolar macrophages 3, 5, and 7
days following silica exposure. Finally, soluble ICAM-1 levels in the BAL fluid were significantly
increased in mice exposed to silica on the same days. Titanium dioxide exposure elicited a minimal
increase in expression of ICAM-1 in the lungs. These data demonstrate that exposure to the toxic
particle silica specifically increases ICAM-1 expression localized to pulmonary macrophages and
type II epithelial cells. - Environ Health Perspect105(Suppl 5):1183-1190 (1997)
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Introduction
Exposure ofmice to silicapartides (a-quartz)
generates an intense inflammatory response
characterized by the influx ofneutrophils
and monocytes into the alveoli (1-3).
Phagocytosis of these silica particles by
inflammatory cells may result in damage to
the lung epithelium through the generation
offree radicals (4-7) and the release oflyso-
somal enzymes (8). In response to injury,
activated macrophages release fibrogenic
factors (2,9,10), which leads to pulmonary
fibrosis (11).
The mechanism by which these
inflammatory cells are recruited to specific
sites in the lung is a complex process involv-
ing the up- and downregulation ofadhesion
molecules on the leukocytes as well as on
lung cells in areas ofpulmonary inflamma-
tion. These molecules are membrane-bound
proteins that function in cell-to-cell interac-
tions, including the migration ofcells from
the blood through the pulmonary intersti-
tium and into the alveolar space (12-14).
One such adhesion protein, intercellular
adhesion molecule-1 (ICAM-1), is expressed
on a variety ofcells including endothelial
cells, fibroblasts, types I and II alveolar
epithelial cells, and monocyte/macrophages
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(15). The cytokines, tumor necrosis factor-a
(TNF-a), interleukin-1 (IL-1), and inter-
feron gamma (IFN-y) upregulate ICAM-1
expression on alveolar macrophages (AM),
endothelial cells, and lung epithelial cells
(15-17). ICAM-1 is capable ofbinding to
the 0-2 integrins LFA-1 (CD1la/CD18)
and Mac-I (CD1lb/CD18), both ofwhich
are expressed on neutrophils (18,19).
Through this interaction, it is hypothe-
sized that neutrophils migrate to areas of
inflammation from the circulation (20).
In addition to the membrane-bound
form ofICAM-1, a circulating form ofthis
protein has been described in human serum
(21). Although the function and source of
soluble ICAM-1 (sICAM-1) are still under
investigation, elevated levels ofthis protein
have been detected in the sera ofpatients
with idiopathic pulmonary fibrosis (22)
and the bronchoalveolar lavage (BAL) fluid
ofratswith fibrotic lung disease (23).
Previous work from this laboratory
documented that silica exposure increased
the amount ofICAM-1 protein in homog-
enized lungs from mice (24). The present
experiments were conducted to localize the
expression ofICAM-1 over the first 7 days
following silica exposure and to compare
the response between mice exposed to silica
and mice exposed to the nuisance dust,
titanium dioxide.
Materials and Methods
Aimas
Adult female C57BL/6 mice (9-15 weeks of
age; Jackson Laboratory, Bar Harbor, ME)
were used in all experiments. Animals were
housed five per cage under horizontal lami-
nar air flow and maintained on a 12-hr
light/12-hr dark cycle in a temperature-con-
trolled animal care facility. Food and tap
water were available adlibitum throughout
all studies.
Instillation ofPartides
Silica crystals (a-quartz; Min-U-Sil 5;
< 5.0 pm; Pennsylvania Glass and Sand,
Pittsburgh, PA) or titanium dioxide (5.0
pm; Sigma Chemical, St. Louis, MO) were
administered as previously described (1).
Briefly, mice were anesthetized by an
ip injection of sodium pentobarbital
(40 mg/kg) and their tracheas exposed by
dissection. Two milligrams ofsilica or tita-
nium dioxide was injected intratracheally
in two bolus doses of1 mg in 0.05 ml ster-
ile saline. Titanium dioxide served as a low
toxicity particle control and sterile saline
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served as a vehicle control. Both the titanium
dioxide and saline were also administered in
two bolus doses, each in 0.05-ml volumes,
similar to the silica injection.
BronchoalveolarLavage
Mice were euthanized by an overdose of
sodium pentobarbital ip at different times
after particle or saline exposure. Lungs
were lavaged in situ three times with 1 ml
sterile saline each; lavage returns of0.95 ml
were similar among all treatment groups.
All lavages were centrifuged at 250 xgfor
10 min at 4°C. The cell-free supernatants
from the first two lavages were pooled and
frozen at -800C for later evaluation of
sICAM-1 levels. The cell pellets from all
three lavages were pooled and assessed for
cell number and type. Cells were resus-
pended in 1% bovine serum albumin in
saline and centrifuged onto a glass slide
using a Shandon cytocentrifuge (Shandon
Southern Instruments, Sewickley, PA).
Specimens were fixed in acetone at 4°C
and stored at-20°C.
MeasurementofSoluble ICAM-1
Soluble ICAM-1 levels were measured by
an antibody sandwich enzyme-linked
immunosorbent assay (ELISA) (Endogen,
Cambridge, MA). BAL fluid samples were
diluted 1:50. Fifty microliters ofsample
was incubated on antibody precoated wells.
After 2 hr, a labeled antibody directed
against sICAM-1 was added. After addition
of substrate, absorbance was read at 450
nm. Simple linear regression was per-
formed using sICAM-1 protein as a stan-
dard and data expressed as nanograms of
sICAM-1/ml recovered BAL fluid.
Isolation ofLungTissueProtein
Lung protein was isolated according to
Syrbu et al. (25). After BAL, the lungs were
perfused through the right ventricle with
sterile phosphate-buffered saline (PBS), pH
7.0. The lungs were excised en bloc and all
surrounding tissue removed. The lungs were
then minced in ice-cold homogenization
buffer (1 mM EGTA, 1 mM PMSF, 1.5 pM
pepstatin, 2 pM leupeptin, 1 pM benzami-
dine, and 1 pg/nil aprotinin in 20 mM Tris-
maleate buffer, pH 7.0). The homogenate
was centrifuged at 11,000 xgfor 10 min at
40C. The supernatants were collected and
centrifuged again at 225,000 xgfor 16 min
at 40C. The resulting pellets were then
resuspended using a Dounce homogenizer
in the homogenization buffer. Aliquots
were frozen at -800C until their evaluation
for levels ofICAM-1 protein.
Enzyme-linkedImmunosorbent
AssayforLungTissueICAM-1
This assay is a modification ofthat described
by Syrbu et al. (25). Five milligrams oflung
protein in 100 pd of0.5-M carbonate buffer,
pH 9.6, was incubated overnight at 40C in a
96-well Immulon-2 (Dynatech Laboratories,
Chantilly, VA) ELISA plate. The next day,
the plate was washed three times with
0.05% tween 20 in PBS (TPBS), pH 8.2.
The wells were then blocked using 0.2%
TPBS for 1 hr at room temperature. The
wells were washed 3 x with TPBS, then the
plate was incubated with 100 pl ofanti-
ICAM-1 antibody (KAT-1; Seikagaku
America; Rockville, MD) for 2 hr at room
temperature. IgG2a (PharMingen; San
Diego, CA) was used as an isotype antibody
control. The wells were washed 3 x with
TPBS, then incubated with peroxidase con-
jugated goat antirat antibody (Sigma
Chemical) for 1 hr at room temperature.
After a final wash (3x) with TPBS, the sub-
strate ABTS and 10 pil H202 were added
and the optical density at 410/490 nm read
(Dynatech MicroELISAplate reader).
PreparationofParenchymal
LungTissue
Lungs were fixed by microwave heating
(26). Briefly, lungs were inflated with ice-
cold saline and the tracheas tied with nylon
thread. The lungs were then placed in
room temperature saline and microwaved
for 5 min at 60°C, then placed in 50%
ethanol. Lungs were embedded in paraffin
and sectioned.
Immunohistochemistry
Both lavaged cells pelleted by cytospin and
fixed lungs processed for immunohisto-
chemistry were assessed for ICAM-1 expres-
sion using the protocol described by the
BioGenex Super Sensitive Detection System
(BioGenex; San Ramon, CA). Briefly,
endogenous peroxidase in specimens was
inactivated byincubation with 3% H202 for
5 min. After two washeswith PBS, the slides
were incubated for 2 hr with YN1/1.7.4
antibody (anti-ICAM-1; gift ofR Rothlein,
Boehringer Ingelheim; Ridgefield, CT) as
the primary antibody. Alternately, serial
lung sections were incubated with rat anti-
mouse TNF-a (PharMingen). The nega-
tive control used for both antibodies was a
nonspecific rat antibody provided by
BioGenex. Following three washes with
PBS, slides were incubated with Link,
biotinylated goat antirat secondary anti-
body. After two washes with PBS, slides
were incubated with Label, horseradish
peroxidase conjugated streptavidin. After
two morewashes with PBS, slides were incu-
bated with substrate and catalyst, amino-9-
ethylcarbazole chromogen and H202.
Counterstaining was performed using
Mayer's hematoxylin. Photomicrographs
(x400, x 1000) were taken under light
microscopy of representative fields. BAL
cells were scored based on staining from 0
to 4 (0, no staining; 4, intense staining).
The number ofcells per score was multi-
plied by that score and totaled to represent
the ICAM-1 immunostaining index.
Statistics
All data are expressed as mean± SE ofthree
to eleven mice for each exposure group for
each time point. Multiple comparisons
were made by two-factor analysis ofvari-
ance followed by the Neuman-Keuls post-
hoc test (Statistica Software, StatSoft;
Tulsa, OK). p< 0.05 was required for
statistical significance.
Results
Silica-induced ICAM-1 Expresion
Instillation ofsilica particles significantly
elevated lung tissue ICAM-1 levels 1 day
after exposure as measured in homogenized
lung tissue by ELISA (Figure 1). This
expression evidenced by immunohistochem-
istry appeared to be localized to alveolar and
interstitial macrophages as well as to type II
epithelial cells (Figure 2A, B). Neither
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Figure 1. sICAM-1 expression in mice lungs following
particle exposure. Mice were exposed to 2 mg/mouse
silica, titanium dioxide, or saline. At various times
postinstillation, the animals were sacrificed and levels
of ICAM-1 in homogenized lung tissue measured by
ELISA. Data are expressed as fold increase above con-
stitutive levels (those detected in naive mice). Each
data point is the mean of three to eight mice±SEM,
p<O.05. *, significantly different from saline-instilled
mice; +, significantly differentfrom TiO2-instilled mice.
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titanium dioxide nor saline instillation
significantly elevated ICAM-1 levels as mea-
sured by ELISA (Figure 1) or by immuno-
histochemistry (Figure 2C, D). Deposition
oftitanium dioxide particles in the lungs
was readily apparent. Exposure to silica
also elicited a marked elevation in TNF-ax
expression, which appeared to be localized
to the same histologic areas with increased
ICAM-1 expression (Figure 3A, B).
AM lavaged from the lungs of silica-
exposed mice also demonstrated increased
expression ofICAM-1 (immunocytochem-
istry) that increased with time. Initially on
A
B
Figure 3. Detection of ICAM-1 and TNF-a in serial lung tissue sections. Mice were exposed to 2 mg/mouse silica
and sacrificed 1 day later. (A) Detection of TNF-a expression appears to be in the same histologic areas as (B)
detection of ICAM-1 expression. Photomicrographs are shown at x400.
days 1 and 3, silica elicited a modest
expression of ICAM-1, detected primarily
on the membranes of AM. However,
5 days after silica exposure, a dramatic
increase in expression of ICAM-1 (Figure
4) was observed associated with both AM
membranes and cytoplasm (Figure 5A).
Neither titanium dioxide nor saline instil-
lation elicited this degree of expression
associated with AM (Figures 4, 5B, C).
Again, titanium dioxide particles engulfed
byAM were apparent.
sICAM-1 was measured in the BAL
fluid ofparticle exposed mice. Significantly
increased levels ofsICAM-1 were found in
the BAL fluid of mice exposed to silica
(Figure 6) with times ofincrease (days 3, 5,
and 7) parallel to increased AM-associated
ICAM-1. Titanium dioxide exposure also
elicited increased levels of sICAM-1, but
well below that observed in silica exposed
animals. Neither particle increased levels of
circulating (plasma) sICAM-1 (data not
shown). Thus, increased levels of ICAM-1
in lung tissue associated with AM, and in
the BAL fluid, were the result ofexposure
to the toxic particle, silica, but not to the
nuisance dust, titanium dioxide.
Silica-induced Pulmonary
Inflammation
Studies were next conducted to examine
cell influx into the airways following expo-
sure to silica or titanium dioxide and the
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Figure 4. Immunostaining index of alveolar
macrophage-associated ICAM-1. Mice were exposed
to 2 mg/mouse silica, titanium dioxide, or saline and
sacrificed at various times postinstillation. BAL cells
were scored based on staining from 0 to 4(0, no stain-
ing; 4, intense staining). The number of cells per score
was multiplied by that score and totaled to represent
the immunostaining index. Each data point for silica-
and titanium dioxide-exposed mice is the mean of
three to four animals±SEM, p<0.05. +, significantly
different from titanium dioxide-instilled mice.
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Figure 6. Levels of sICAM-1 in the BAL fluid. Mice
were exposed to 2 mg/mouse silica, titanium dioxide,
or saline and sacrificed at various times postinstilla-
tion. Levels of sICAM-l were measured by ELISA and
data are expressed as ng/ml lavage fluid. Each data
point is the mean of four mice±SEM, p<0.05. *, sig-
nificantly different from saline-instilled mice; +, signifi-
cantly different from titanium dioxide-instilled mice.
relationship between cell trafficking and
ICAM-1 expression. Figure 7A demon-
strates that silica exposure significantly
increased the number oflavageable neu-
trophils (1, 3, 5, and 7 days after exposure)
and macrophages (3, 5, and 7 days after
exposure). With time, the increase in AM-
associated ICAM-1 (Figure 4) and sICAM-1
(Figure 6) paralleled the increase in the
number ofAM. Figure 7B demonstrates
that titanium dioxide exposure also signifi-
cantly increased the number oflavageable
neutrophils and macrophages, but well
below that observed following silica expo-
sure. There was no apparent association
between the low level ofsICAM-1 detected
(Figure 6) and inflammatory cell influx in
these mice.
Discussion
Levels of ICAM-1 were increased in lung
tissue of mice following exposure to the
toxic particle, silica, but not to the nui-
sance dust, titanium dioxide. This increase
in ICAM-1 could be localized by immuno-
histochemistry to aggregates ofpulmonary
macrophages and to type II epithelial cells.
Exposure to silica also elicited increased
expression ofTNF-x, which appeared to
be localized to the same areas of the
lung with increased ICAM-1 expression.
Immunocytochemical analysis ofcells iso-
lated by BAL showed that ICAM-1 expres-
sion was increased in AM from animals
exposed to silica. In addition, an increase in
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day 5 (Figure 7A). The peak in detection of
sICAM in lung lavage fluid 5 days after sil-
ica (Figure 6) also appears to reflect the
increased number and ICAM-1 expression
on these cells at this time. Increased ICAM-
1 expression in lung tissue, on the other
hand, can be localized not only to AM, but
also to interstitial macrophages and type II
cells. The marked increase in ICAM-1
expression in lung parenchyma may reflect
activation ofresident cells by silica particles
that are passing across the alveolar epithelial
barriers prior to reaching afferent lymphatic
channels (27). Past work in this mouse
model documents detectable silica in the
mediastinal lymph nodes as early as 1 day
after silica exposure (28).
ICAM-1 is elevated in several models of
antigen independent lung injury. The role
of ICAM-1 in these models, as in other
models oflung injury, is in participation in
the inflammatory response generated by
toxic insults. ICAM-1, through its interac-
tion with its ligands, the 02-integrins
(CD11a/CD18 or CD11b/CD18) on the
surface of leukocytes, functions in the
* I / adherence and migration ofleukocytes
(20). Studies have shown that an increase
in ICAM-1 expression on the surface of
* endothelial cells is associated with an
* * l S increase in neutrophil adhesion (19,29)
and transendothelial migration (29,30).
Exposure of mice to hyperoxia increased
pulmonary ICAM-1 protein (14,31,32)
and mRNA (32), whereas airway epithelial
Time postinstillation, days cells in mice increase ICAM-1 protein after
3 hr exposure to ozone (33). Intratracheal
Silica-induced cellular inflammation. Mice injection of Sephadex beads (Pharmacia,
osed to 2 mg/mouse (A) silica or (B titanium Uppsala, Sweden) in a murine foreign
nd sacrificed at various times postinstillation. body granulomatous lung model increased
total number of PMNs (filled symbols) and AM expression of ICAM-1 in alveolar inflam-
mbols) were counted in the BAL fluid and matory cells and on lung parenchymal tis-
as cell numberx103/ml BALfluid. Each data sue (34) and exposure ofrats to oleic acid
e mean offourtoeleven mice±SEM,p<0.05. also increased pulmonary ICAM-1 protein
antlydifferentfromsaline-instilled mice. levels (25).
The role of increased expression of
ICAM-1 was measured in the cell- ICAM-1 associated with AM following sil-
L fluid following silica exposure. ica exposure remains unclear. However, the
increases in ICAM-1 were not presence ofICAM-1 on the surface ofAM
I to the same extent in mice exposed may indicate a level ofsilica-induced cell
Luisance dust, titanium dioxide. activation on newly recruited AM.
tection of ICAM-1 expression Rothlein et al. (35) have shown that cross-
ted with lavaged AM was greatest 5 linking of ICAM-1 on the surface of
ter silica exposure, whereas detection peripheral blood mononuclear leukocytes
ased ICAM-1 in lung homogenates with a monoclonal anti-ICAM-1 antibody
) and in lung tissue (immunohisto- results in the generation of an oxidative
:ry) was greatest on day 1. Increased burst, which suggests the capability of
-1 expression associated with AM ICAM-1 to deliver a transmembrane sig-
Rect elevated ICAM-1 expression on nal. Others have also documented an asso-
recruited AM, as the peak in the ciation between increased AM ICAM-1
r of lavaged AM was also seen on expression in fungi-activated AM (36), in
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AM from asthma patients (37), and AM
from patients with active sarcoidosis (38).
Interestingly, we did not detect a
marked increase in endothelial cell ICAM-1,
yet previous studies in our lab demonstrated
that passive immunization of mice with an
antibody directed against ICAM-1 reduced
silica-induced neutrophil influx into the air-
ways by approximately 50% (24). The
increased levels of ICAM-1 on the mem-
brane ofAM may promote interactions with
other leukocytes (e.g., neutrophils), further
stimulating these macrophages to perpetuate
the inflammatory response. Passive immu-
nization with anti-ICAM-1 antibody may
have interfered with this process and thus
reduced the phlogistic signals responsible for
the migration ofneutrophils.
Silica exposure also increased levels
of sICAM-1 protein in the BAL fluid.
sICAM-1 detected in the BAL fluid may be
from pulmonary leukocytes (21) or alveolar
epithelial cells (22). Because we detected
ICAM-1 associated with AM following sil-
ica exposure, these cells are the most likely
source in our model. This form ofICAM-
1 is probably the result of proteolytic
cleavage of cell-bound ICAM-1 close to
the cell membrane, as it has been reported
to contain most of the extracellular por-
tion ofthe membrane-bound form (21). It
may also be the result of an alternatively
spliced form of mRNA lacking a trans-
membrane domain (39). The role for
sICAM-1 remains unknown. Others have
speculated that plasma sICAM-1 may bind
to activated neutrophils (PMNs), thus
reducing theiradherence to endothelial cells
and subsequent extravasation (21). Its
increase in BAL fluid may be a marker of
fibrosis (23), inflammation, tissue damage,
and nonspecific proteolysis, rather than
serving a physiological role (21). Indeed,
the small increase in sICAM detected in
BAL oftitanium dioxide-exposed mice may
reflect the limited inflammatory response
observed with this low toxicity particle.
Cytokines TNF-a, IL-1, and IFN-y
upregulate ICAM-1 expression on alveolar
epithelial and endothelial cells (15-17).
The ability of these cytokines to promote
the recruitment of PMNs may be due to
their ability to upregulate adhesion mole-
cule expression (40,41). These cytokines,
which increase ICAM-1 expression, are
also elicited from macrophages exposed in
vitro or in vivo to silica. Driscoll et al. (2)
have shown that TNF-a release is increased
from AM lavaged from rats exposed to sil-
ica but not to titanium dioxide. More
recently Ohtsuka et al. (3) reported TNF-
x release from AM from silica-injected
mice. Furthermore, Piguet et al. (42) have
shown that passive immunization of mice
with an antibody directed against TNF-a
reduces silica-induced collagen deposition.
Cytokines elicited by silica exposure may
also be responsible for increased ICAM-1
expression on type II epithelial cells. Kang
et al. (17) demonstrated in mice that nasal
instillation of either TNF-a or IFN-y
increased ICAM-1 expression on type II
epithelial cells by >20-fold. This induction
may be the result ofdifferentiation oftype
II cells to replace injured type I epithelial
cells (43) and/or ofa response to cytokines
released during inflammation. It is well
documented that exposure oftype II cells
to silica initiates repair, replication, and
growth ofthese cells (44).
Thus, it can be speculated that the
increase in ICAM-1 following silica expo-
sure may be due in part to an increased
expression of cytokines such as TNF-x.
The apparent colocalization of both
ICAM-1 and TNF-a by immunohisto-
chemistry provides evidence to support this
proposal. Increased TNF-aX expression on
pulmonary macrophages and on type II
epithelial cells may represent the presence
ofTNF-a bound to its receptor, which in
turn increases the expression ofICAM-1 at
the same histopathological sites. The
inability of titanium dioxide to increase
ICAM-1 levels may pertain to its inability
to substantially increase expression of
TNF-a (2).
This study documents that exposure of
mice to the toxic particle, silica, specifi-
cally increases ICAM-1 expression in the
lungs, which can be localized to pul-
monary macrophages and type II epithelial
cells. Increased TNF-a expression appears
to be colocalized to the same histopatho-
logic areas with increased ICAM-1 expres-
sion. Increased ICAM-1 expression also
appears to be increased on newly recruited
AM with subsequent shedding of cell
bound ICAM-1 into the BAL fluid.
Future studies will continue to focus on
the mechanism ofinduction and the speci-
ficity/sensitivity of increased ICAM-1
expression following exposure to other
toxic inorganic particles.
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